CD19 CAR-T Cells Treatment Conferred a Sustained Remission in Patients with Chemotherapy-Refractory MRD in B-ALL
Wenyi Lu(Tianjin First Center Hospital), Mingfeng Zhao(Nankai University), Haibo Zhu(Tianjin First Center Hospital), Xin Li(Heilongjiang Vocational Institute of Ecological Engineering), Qing Li(Tianjin First Center Hospital), Xia Xiao(Hebei Medical University), Xiaoyuan He(Nankai University), Kaiqi Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Rui Sun(Nankai University), Yaqing Cao(Tianjin Medical University), Yanyu Jiang(Nankai University), Yili Jiang(Nankai University), Huan Zhang(Tianjin First Center Hospital), Tao Sui(Tianjin First Center Hospital), Yunxiong Wei(Tianjin First Center Hospital), Xin Jin(Nankai University), Jia Wang(Shantou University), Hairong Lyu(University of Bristol)
Cited by 0
Related Papers
Complete Revascularization with Multivessel PCI for Myocardial Infarction
|New England Journal of Medicine|2019|926
The significance of exosomes in the development and treatment of hepatocellular carcinoma
|Molecular Cancer|2020|509
The genesis and source of the H7N9 influenza viruses causing human infections in China
|Nature|2013|479
Chitosan Ameliorates DSS-Induced Ulcerative Colitis Mice by Enhancing Intestinal Barrier Function and Improving Microflora
|International Journal of Molecular Sciences|2019|245
Iron-dependent histone 3 lysine 9 demethylation controls B cell proliferation and humoral immune responses
|Nature Communications|2019|224